+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Active, Not Recruiting

Phase 3
Age: 18Years +
All Genders
ID07222748

A Phase 3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy

Led by TLC Biopharmaceuticals, Inc. · Updated on 2026-07-02

304

Participants Needed

4

Research Sites

2 weeks

Total Duration

AI-Summary

What This Trial Is About

This is a Phase 3, randomized, double-blind, comparator- and placebo-controlled study to evaluate analgesic efficacy and safety of TLC590 via local infiltration in adult subjects following bunionectomy.

CONDITIONS

Brief Title

A Study of TLC590 for Postsurgical Pain Following Bunionectomy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here